The Limited Times

Now you can see non-English news...

Modern vaccine booster for omicron is already in development

2021-12-20T14:54:38.656Z


Moderna continues to work on developing a booster vaccine that specifically targets omicron and other variants.


The reasons why Klopp defends the covid-19 vaccine 0:39

(CNN) -

The biotech company Moderna continues to work on developing a booster vaccine that specifically targets omicron and other variants, company president Dr. Stephen Hoge said Monday.


"We will continue to make progress in developing an omicron-specific booster in clinical trials in early 2022," Hoge said during a company conference call.

  • Moderna booster dose raises omicron antibody levels, company says

For now, Moderna plans to focus its "immediate efforts" around omicron with the current vaccine that is now available, Hoge said.

Moderna's current booster coronavirus vaccine is licensed for emergency use in the United States and is administered as a half dose at 50 micrograms.

Moderna vaccine against omicron

Moderna announced Monday that preliminary data suggests her half-dose booster dose increased antibody levels 37 times against Omicron compared to levels seen when a fully vaccinated person does not receive a booster, but rather a larger booster dose. , at 100 micrograms, increases antibody levels 83 times.

It is not clear what these increases mean in terms of how well the omicron booster doses work clinically.

advertising

  • Harsh winter in the US: Fauci warns that the omicron variant will be dominant in the coming weeks

But in the company statement, CEO Stéphane Bancel called the data "reassuring."

"The dramatic increase in covid-19 cases from the omicron variant worries us all. However, this data showing that the currently licensed Moderna covid-19 booster can increase neutralizing antibody levels 37 times higher than those pre-boost levels are reassuring, "Bancel said in the announcement.

"To respond to this highly transmissible variant, Moderna will continue to rapidly advance a specific omicron booster candidate in clinical trials should it be needed in the future. We will also continue to generate and share data through our booster strategies with authorities. to help them make evidence-based decisions about the best vaccination strategies against SARS-CoV-2. "

Source: cnnespanol

All news articles on 2021-12-20

You may like

News/Politics 2024-02-15T06:00:59.458Z

Trends 24h

News/Politics 2024-03-27T16:45:54.081Z
News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.